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Two-phase biocatalysis is commonly used for the bioconversion of water-insoluble chemical and pharmaceutical 
compounds. In research laboratories, such processes often take place in flasks and are driven and limited by slow diffusive 
processes. In this work, we developed droplet-based microfluidic systems and used them to perform testosterone 
dehydrogenation. The use of microdroplets as reaction vessels offers the advantage of greatly improved diffusion rates 
due to significantly increased surface-to-volume ratio. We found that indeed reaction time was reduced from tens of 
minutes to tens of seconds without sacrificing conversion efficiency. This demonstrates the potential of droplet-based 
two-phase biocatalysis. 
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INTRODUCTION 
In biocatalysis, enzymes or whole cells are used as catalysts 
for chemical transformations. Compared to chemical 
methods, biocatalysis offers several advantages such as 
high specificity, environmental friendliness, and reduced 
energy requirements due to reactions at room temperature 
and atmospheric pressure [Anthonsen, 2000; Faber, 2011]. 
Enzymes used as catalysts for chemical reactions are 
generally less stable in organic media compared to their 
natural aqueous environment, but chemical and 
pharmaceutical compounds are often insoluble in water 
[Klibanov, 2001]. The use of aqueous/organic two-phase 
systems provides a solution to this problem. Such two-
phase systems are now commonly used in multiple 
biotransformations [Adebar, 2019]. The addition of a non-
polar organic phase as a substrate reservoir and product 
sink can ensure high substrate loadings while avoiding 
enzyme inhibition or inactivation. 
Figure 1 shows a simplified example of a traditional 
aqueous/organic two-phase system. In this configuration, 
biocatalysis is driven by diffusion. The substrate diffuses 
into the aqueous phase, where it is converted by the 
enzyme. In turn, the product diffuses back into the organic 
phase, where it is 
collected. Diffusion 
is often facilitated 
by shaking the 
flasks or stirring 
their contents. 
Mixing increases 
the contact area 
between the two 
phases, but at the 
same time 
mechanical stress 
associated with shaking or stirring can cause enzyme 
denaturation. The formation of emulsions during stirring is 
also a limitation of such systems, as phases are difficult to 
separate for product collection. Additionally, the amount or 
type of organic phase can also have an inhibitory effect on 
the reaction, as it can impede enzyme activity. 
 
RESEARCH CONCEPT 
In this work, we designed, fabricated, and tested 
microfluidic devices for droplet-based two-phase 
biocatalysis on-chip. The use of microfluidic droplets as 





miniaturized reactors offers the advantage of greatly 
improved diffusion rates due to the significantly increased 
surface-to-volume ratio [Žnidaršič-Plazl, 2014; Fernandes, 
2010]. In turn, higher diffusion rates can increase the 
reaction conversion rate. Another advantage of 
microfluidic droplets is lack of mechanical stress 
associated with their formation and their relative ease of 
separation compared to emulsions created by active mixing 
in flasks. Microdroplet separation ensures efficient product 
extraction. 
 
ENZYME-BASED BIOCATALYTIC REACTION 
17β-Hydroxysteroid dehydrogenases (17β-HSDs) are a 
type of NAD(P)-dependent oxidoreductases. Their main 
function is to participate in the metabolism of sex hormones 
by controlling the last step in the formation of androgens 
and estrogens. Thus, they play an important role in 
reproduction [Oppermann, 1996; Benach, 1996]. Herein, 
17β-hydroxysteroid dehydrogenase is used for testosterone 
dehydrogenation to androstenedione, as shown in Figure 2 
below. 
Androstenedione can be used as a precursor of hormones, 
such as male hormones and protein synthesis hormones, 
and can be used to synthesize pharmaceuticals such as 
spironolactone, hydrocortisone, prednisone oxide, and 
dexamethasone [Elks, 2014]. Testosterone is the main 
protein assimilation substance, and it is of great 
significance to health, affecting, among others, sexual 
desire, strength, and immune function [Mooradian, 1987]. 
 
MICROFLUIDIC DEVICE DESIGN AND 
FABRICATION  
There are three typical microfluidic device architectures 
used to generate droplets: T-junctions, flow-focusing 
devices, and co-flowing devices [i Solvas, 2011]. The 
experiments described in this work were carried out in 
flow-focusing devices.  
The droplets produced have an oil-in-water (O/W) 
structure. The continuous phase is a buffer containing the 
enzyme, and the discrete phase is an organic solvent 
containing the substrate testosterone. Figure 3 shows the 
geometry of the microfluidic device used in this study. To 
generate droplets, the continuous phase "squeezes" the 
fluid front of the dispersed phase from both sides of the 
intersection, and uses the "neck" structure of the channel 
downstream of the liquid front to form discrete droplets. 
The width of the continuous-phase microchannel, 𝑤𝑐𝑜𝑛, is 
110 μm and the width of the discrete-phase microchannel, 
𝑤𝑑𝑖, is 60 μm. The two phases converge in a narrow "neck" 
with a width of 50 μm and form droplets in a 400 μm 
channel.  
The microfluidic devices were fabricated in glass using 
femtosecond laser ablation. Glass was chosen due to its 
chemical inertness, which ensures no effects on the 
biocatalytic reaction. After laser ablation of microchannels, 
the glass wafer with a thickness of 700 nm was etched in 
hydrofluoric acid to remove surface defects, followed by 
cleaning in piranha solution (a mixture of sulfuric acid, 
water, and hydrogen peroxide), accompanied by an 
increase in surface hydrophilicity. To seal the microfluidic 
channels, the base wafer was thermally bonded to a cover 
glass wafer. The finished microfluidic device was therefore 
made exclusively out of transparent glass, which also 
allows the use of microscopy for process monitoring. 
 
Figure 2: Conversion of testosterone to 
androstenedione catalyzed by 17β-hydroxysteroid 
dehydrogenase. 






The aqueous phase and organic phase solutions were 
prepared before the start of the experiment. 50 µl of a 10 
µg/µl enzyme solution, 1000 µl of 20 mM nicotinamide 
adenine dinucleotide (NAD+) and 3450 µl of buffer were 
mixed to form the aqueous phase. The buffer was 
composed of 20 mM Tris-HCl and 25 mM sodium chloride 
at pH 9. Methyl tertiary butyl ether (MTBE) was chosen as 
the organic solvent, in which the concentration of 
testosterone was 10 mM. In addition, 1% Tween 20 was 
added to the aqueous phase as a surfactant to reduce the 
surface tension and promote the formation and stabilization 
of the droplets.  
 
CONTINUOUS BIOCATALYTIC REACTIONS IN 
MICRODROPLETS 
Syringe pumps were used to push the organic and aqueous 
phase into microchannels, and experiments were carried 
out at two flow rates. In sample 1, the flow rate of the 
organic phase was 1.5 µl/min, and the flow rate of the 
aqueous phase was 4.5 µl/min. In sample 2, the flow rates 
of the organic and aqueous phases were 3 µl/min and 9 
µl/min, respectively. At the outlet of the microfluidic 
system 250 µl of liquid was collected for analysis. Ethyl 
acetate was added to the collection container at a ratio of 
1:1 (ethyl acetate to reaction solution) to terminate the 
reaction. In addition, a 6 cm-long PTFE tube with an inner 
diameter of 0.25 mm was installed at the outlet of the glass 
microfluidic chip to provide a longer residence time for the 
reaction. The residence time (i.e. reaction time) of the 
reaction solution in the system was approximately 40 s 
(sample 1) and 20 s (sample 2). 
The droplets generated in the microchannel are shown in 
Figure 4. The average droplet diameter was approximately 
80 μm. 
 
RESULTS AND DISCUSSION 
High performance liquid chromatography (HPLC) was 
used for the detection of substrate and product in the 
solution. Figure 5 below shows the chromatogram of the 
reaction in sample 1. By calculating the ratio of the peak 
areas of the product and the substrate, the conversion of the 
substrate testosterone to the product androstenedione in the 
two reactions was determined as follows: sample 1: 91%, 
sample 2: 85%. The corresponding amount of the produced 
product were 0.5687 µmol and 0,53125 µmol, respectively. 
The same experiment was performed in a conventional 
batch reaction at the same substrate concentration of 10 
mM and stirring at 900 rpm. The concentration of enzyme 
in the buffer was 50 µg/ml. As using large amounts of 
organic solvent can affect the activity of the enzyme, the 
ratio of the organic to aqueous phase used was 1:9. At a 
reaction time of 10 minutes, the conversion rate was 85 %. 
After 15 minutes, the conversion rate increased to 93 %. 
 
CONCLUSIONS 
The dehydrogenation reaction of testosterone catalyzed by 
17β-HSD was realized in microdroplets and was compared 
to traditional batch experiments. We found that high 
conversion rates can be achieved in such miniaturized 
systems in significantly less time (tens of seconds) 
compared to the traditional setup (tens of minutes).  This is 
partially due to much higher diffusion rates achieved in 
microsystems facilitated by the large droplet surface-to-
volume areas. Therefore, such miniaturized reactors are a 
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Figure 4: Microdroplets in the microchannel. The flow 
rate of the organic phase is 1.5 µl/min, and the flow rate 
of the water phase is 4.5 µl/min. Observed under a 
microscope. For scale, the width of the microchannel 
that contains droplets is 400 µm. 
Figure 5: The chromatogram of the substrate and product 
in sample 1, where the abscissa represents the retention 
time and the ordinate represents the intensity. The 
retention times of testosterone and androstenedione are 6.2 
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